# OnCo record nct06474806 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06474806/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06474806", "NCT06474806" ;
  schema:name "Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer"@en ;
  schema:alternateName "uTRACE-101"@en ;
  schema:description "A phase 2 trial of 64Cu-DOTA-AE105 in prostate cancer, run by Curasight, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06474806/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06474806> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-06-01" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/pet/> .
